Invention Grant
US07001619B2 Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
有权
对药物对CYP 450生物活化肝毒性的肝胆管作用
- Patent Title: Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
- Patent Title (中): 对药物对CYP 450生物活化肝毒性的肝胆管作用
-
Application No.: US10106119Application Date: 2002-03-27
-
Publication No.: US07001619B2Publication Date: 2006-02-21
- Inventor: Rakesh Kamal Johri , Sheikh Tasaduq Abdullah , Kuldeep Singh , Devinder Kumar Gupta , Bal Krishan Kapahi , Dilip Manikrao Mondhe , Satinder Mohan Jain , Om Parkash Suri , Kasturi Lal Bedi , Ghulam Nabi Qazi
- Applicant: Rakesh Kamal Johri , Sheikh Tasaduq Abdullah , Kuldeep Singh , Devinder Kumar Gupta , Bal Krishan Kapahi , Dilip Manikrao Mondhe , Satinder Mohan Jain , Om Parkash Suri , Kasturi Lal Bedi , Ghulam Nabi Qazi
- Applicant Address: IN New Delhi
- Assignee: Council of Scientific and Industrial Research
- Current Assignee: Council of Scientific and Industrial Research
- Current Assignee Address: IN New Delhi
- Agency: Smith, Gambrell & Russell, LLP
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/20 ; A61K35/00 ; A61K35/78
Abstract:
The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity.
Public/Granted literature
- US20030185922A1 Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs Public/Granted day:2003-10-02
Information query
